DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $350,207 | -0.3% | 27,532 | +10.4% | 0.04% | +7.1% |
Q2 2023 | $351,275 | +13.9% | 24,949 | +24.9% | 0.04% | +7.7% |
Q1 2023 | $308,512 | +29.9% | 19,968 | +37.8% | 0.04% | +25.8% |
Q4 2022 | $237,475 | +14.7% | 14,489 | +29.5% | 0.03% | +6.9% |
Q3 2022 | $207,000 | – | 11,188 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |